Sasitorn Siritho
Overview
Explore the profile of Sasitorn Siritho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Budtarad N, Ongphichetmehta T, Siritho S
Sci Rep
. 2025 Feb;
15(1):4011.
PMID: 39893222
Our study focused on assessing disease and pregnancy outcomes in Thai patients with Neuromyelitis Optica Spectrum Disorder (NMOSD), a condition that disproportionately affects women of childbearing age and poses risks...
2.
Songthammawat T, Srisupa-Olan T, Siritho S, Kittisares K, Jitprapaikulsan J, Sathukitchai C, et al.
Mult Scler Relat Disord
. 2024 Dec;
93:106233.
PMID: 39709699
No abstract available.
3.
Chien C, Cruz E Silva V, Geiter E, Meier D, Zimmermann H, Bichuetti D, et al.
Radiology
. 2024 Nov;
313(2):e233099.
PMID: 39530897
Background Patients with neuromyelitis optica spectrum disorder (NMOSD) are often seropositive for antibodies against aquaporin-4 (AQP4). The importance of MRI monitoring in this disease requires evaluation. Purpose To profile MRI...
4.
Apiraksattayakul N, Lerttanatum C, Maethasith I, Wongsripuemtet J, Siritho S, Jitprapaikulsarn J, et al.
Sci Rep
. 2024 Aug;
14(1):20201.
PMID: 39215043
This study aimed to identify the prevalence, clinical and radiographic characteristics, and risk factors for cognitive dysfunction in patients with Neuromyelitis optica spectrum disorder (NMOSD). Eighty-three participants who were diagnosed...
5.
Intarakhao P, Laipasu T, Jitprapaikulsan J, Apiraksattayakul N, Kosiyakul P, Siritho S, et al.
Ann Clin Transl Neurol
. 2024 Aug;
11(10):2707-2718.
PMID: 39186371
Objective: To evaluate the efficacy of rituximab (RTX) in stabilizing disability progression in secondary progressive multiple sclerosis (SPMS). Methods: A systematic review was conducted, encompassing studies from inception to April...
6.
Klyscz P, Asseyer S, Alonso R, Bereuter C, Bialer O, Bick A, et al.
Ann Clin Transl Neurol
. 2024 Aug;
11(9):2473-2484.
PMID: 39099240
Objective: The first international consensus criteria for optic neuritis (ICON) were published in 2022. We applied these criteria to a prospective, global observational study of acute optic neuritis (ON). Methods:...
7.
Kosiyakul P, Jitprapaikulsan J, Rattanathamsakul N, Siritho S, Sangsai O, Aueaphatthanawong K, et al.
Curr Ther Res Clin Exp
. 2024 May;
100:100749.
PMID: 38808155
Background: Complementary and alternative medications (CAM) are common among patients with multiple sclerosis (MS) for physical and psychological support. However, there is insufficient data regarding the application of CAM in...
8.
Viswanathan S, Vijayasingham L, Laurson-Doube J, Quek A, Tan K, Yeo T, et al.
Mult Scler Relat Disord
. 2024 Mar;
85:105555.
PMID: 38547547
Background: Despite the global availability of multiple sclerosis (MS) treatments, accessing and financing them in Southeast Asia (SEA) remains a challenge. This descriptive survey-based study aimed to describe the current...
9.
Ongphichetmetha T, Aungsumart S, Siritho S, Apiwattanakul M, Tanboon J, Rattanathamsakul N, et al.
Sci Rep
. 2024 Mar;
14(1):5332.
PMID: 38438530
No abstract available.
10.
Ongphichetmetha T, Jitprapaikulsan J, Siritho S, Rattanathamsakul N, Detweeratham T, Prayoonwiwat N
Sci Rep
. 2024 Feb;
14(1):3503.
PMID: 38347079
In Thailand, resource limitations lead many multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) patients to use off-label immunosuppressants. This study assesses the efficacy and safety of rituximab (RTX)...